top of page

FOXO4-DRI 10mg (Proxofim) 

Advanced Senolytic Research Compound for Cellular Aging Studies

Product Overview

FOXO4-DRI (D-Retro-Inverso), also known as Proxofim, is a cutting-edge synthetic peptide designed for advanced aging research and cellular senescence studies. This innovative compound represents a breakthrough in senolytic research, offering researchers a powerful tool to investigate cellular aging mechanisms and potential therapeutic applications.

Key Features & Benefits

✓ Selective Senolytic Activity: FOXO4-DRI demonstrates remarkable selectivity in targeting senescent cells while preserving healthy cell populations

✓ Enhanced Stability: The D-retro-inverso modification provides superior resistance to proteolytic degradation, extending half-life and bioavailability

✓ Cell-Penetrating Design: Engineered with HIV-TAT sequence for efficient cellular uptake and sustained intracellular presence

✓ Research Validated: Extensively studied in peer-reviewed research with applications in aging, fibrosis, and regenerative medicine

Mechanism of Action

FOXO4-DRI functions through a sophisticated molecular mechanism:

  • Disrupts FOXO4-p53 Interaction: Competitively binds to p53, preventing normal FOXO4 sequestration

  • Induces Nuclear p53 Exclusion: Releases p53 from nuclear sequestration, allowing translocation to mitochondria

  • Triggers Selective Apoptosis: Activates caspase-3/7 pathways specifically in senescent cells

  • Preserves Healthy Cells: Shows minimal impact on non-senescent cell populations

 

Research Applications

 

Aging & Longevity Studies: Investigate cellular senescence mechanisms and potential life extension strategies

Tissue Regeneration: Study applications in cartilage repair, wound healing, and organ function restoration

Fibrosis Research: Explore therapeutic potential in pulmonary fibrosis and other fibrotic conditions

Reproductive Health: Investigate age-related reproductive decline and testosterone insufficiency

Cardiovascular Research: Study heart disease prevention through proteasome activity enhancement

Neurodegeneration Studies: Explore potential applications in Alzheimer's, Parkinson's, and other neurodegenerative diseases

Technical Specifications

Molecular Formula: C₂₂₈H₃₈₈N₈₆O₆₄
Molecular Weight: 5,358.05 Da
Purity: >98% (HPLC verified)
Appearance: White lyophilized powder
Storage: Store at -20°C, protect from light
Solubility: Soluble in sterile water or saline

Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH

Research Highlights

Recent studies have demonstrated FOXO4-DRI's potential across multiple research areas:

  • Improved Organ Function: Animal studies show enhanced fitness, fur density, and renal function in aged mice

  • Tissue Homeostasis: Restoration of tissue balance through selective elimination of dysfunctional cells

  • Reduced Inflammation: Decreased senescence-associated secretory phenotype (SASP) markers

  • Enhanced Regeneration: Improved cellular regeneration capacity in various tissue types

 

Quality Assurance

 

Each batch undergoes rigorous quality control testing:

  • High-Performance Liquid Chromatography (HPLC) purity verification

  • Mass spectrometry molecular weight confirmation

  • Sterility and endotoxin testing

  • Certificate of Analysis provided with each order

Usage Guidelines

For Research Use Only: FOXO4-DRI is intended exclusively for in-vitro research and scientific studies. Not approved for human consumption or therapeutic use.

Recommended Protocols: Consult current literature for optimal concentration ranges and experimental conditions. Initial studies suggest effective concentrations in the micromolar range for cell culture applications.

Safety Considerations: Handle with appropriate laboratory safety equipment. Store properly to maintain stability and potency.

Why Choose PeptidesAlpha?

  • Premium Quality: Pharmaceutical-grade synthesis with >98% purity

  • Fast Shipping: Rapid, secure delivery with proper cold-chain handling

  • Expert Support: Technical assistance from our peptide specialists

  • Competitive Pricing: Best value for research-grade peptides

  • Reliable Supply: Consistent availability for ongoing research projects

Order Information

Product Code: PA-FOXO4-DRI-10MG
Package Size: 10mg lyophilized powder
Storage Requirements: -20°C freezer storage recommended
Shelf Life: 24 months when stored properly

Transform your aging research with FOXO4-DRI from PeptidesAlpha - where cutting-edge science meets uncompromising quality.

FOX04-DRI 10mg

₹60,000.00Price
Quantity
    • Typical dosages can range, but commonly it’s 2mg per vial, which can be reconstituted with sterile water.
    • The peptide is typically administered via subcutaneous injection.
    • The dosing regimen often involves one injection per week, as it has a prolonged half-life (due to the DAC component).
    • As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity.
    • It’s important to monitor health regularly and consult with a healthcare provider, especially if using for long-term purposes.

     

bottom of page